JPH038759B2 - - Google Patents
Info
- Publication number
- JPH038759B2 JPH038759B2 JP10134581A JP10134581A JPH038759B2 JP H038759 B2 JPH038759 B2 JP H038759B2 JP 10134581 A JP10134581 A JP 10134581A JP 10134581 A JP10134581 A JP 10134581A JP H038759 B2 JPH038759 B2 JP H038759B2
- Authority
- JP
- Japan
- Prior art keywords
- citric acid
- immobilized
- reaction
- solution
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 78
- 244000005700 microbiome Species 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 235000000346 sugar Nutrition 0.000 claims description 9
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 239000000679 carrageenan Substances 0.000 claims description 5
- 229920001525 carrageenan Polymers 0.000 claims description 5
- 229940113118 carrageenan Drugs 0.000 claims description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 5
- 229920002401 polyacrylamide Polymers 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 150000008163 sugars Chemical class 0.000 claims description 4
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 239000000783 alginic acid Substances 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 229960001126 alginic acid Drugs 0.000 claims description 3
- 150000004781 alginic acids Chemical class 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 229930014626 natural product Natural products 0.000 claims 1
- 239000000243 solution Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 11
- 239000000499 gel Substances 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 238000005273 aeration Methods 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- MTPJEFOSTIKRSS-UHFFFAOYSA-N 3-(dimethylamino)propanenitrile Chemical compound CN(C)CCC#N MTPJEFOSTIKRSS-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000021536 Sugar beet Nutrition 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 241000235015 Yarrowia lipolytica Species 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000807905 Corynebacterium glutamicum ATCC 14067 Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011437 continuous method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940111688 monobasic potassium phosphate Drugs 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- ILRLTAZWFOQHRT-UHFFFAOYSA-N potassium;sulfuric acid Chemical compound [K].OS(O)(=O)=O ILRLTAZWFOQHRT-UHFFFAOYSA-N 0.000 description 1
- 239000011949 solid catalyst Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明はゲル状担体に固定したクエン酸生成能
を有する微生物を糖液と接触反応させクエン酸を
製造する方法にかゝり、詳しくは、あらかじめ培
養して得られるアスパジラス属、カンジダ属など
のクエン酸生成能を有する菌株の菌体または胞子
を、ポリアクリルアミド、カラギーナン、アルギ
ン酸などのゲル担体に抱括固定し、該固定化微生
物を糖類と接触反応させる方法である。この方法
では、いわゆる発酵法の如く、複雑な副生物は非
常に少なく、精製に容易な状態で工程が管理でき
る。Detailed Description of the Invention The present invention relates to a method for producing citric acid by contacting and reacting microorganisms capable of producing citric acid immobilized on a gel-like carrier with a sugar solution. This is a method in which the cells or spores of a bacterial strain capable of producing citric acid, such as Aspadillas or Candida, are immobilized in a gel carrier such as polyacrylamide, carrageenan, or alginic acid, and the immobilized microorganism is brought into contact with sugars. . In this method, unlike the so-called fermentation method, there are very few complicated by-products, and the process can be managed in a state where purification is easy.
近年、固定化微生物を用いる有用な物質を生成
させる方法が試みられ、たとえば酵母を使つたア
ルコールをグルコースから製造する方法がその代
表例として挙げられる。しかしながら複雑な生体
反応により生成するクエン酸を、アルコールの例
のごとく効率よく、しかも、α−ケトグルタール
酸、グルコン酸などの副生をともない易い生体反
応で得ようとする試みは全く無く、本発明をもつ
て最初とする。 In recent years, methods for producing useful substances using immobilized microorganisms have been attempted, and a typical example is a method for producing alcohol from glucose using yeast. However, there has been no attempt to obtain citric acid, which is produced through a complex biological reaction, as efficiently as in the case of alcohol, but also through a biological reaction that easily produces by-products such as α-ketoglutaric acid and gluconic acid. be the first.
本発明者は、一般にクエン酸発酵生産にもちい
られるアスパジラス・ニガー(Aspergillus
niger)やカンジダ・リポリテイカ(Candida
lipolytica)などの培養菌体または胞子を、ポリ
アクリルアミド、カツパ・カラギーナンあるいは
アルギン酸カルシウムの各種ゲルに包括固定化
し、これを球状またはブロツク状に成型させ、こ
の成型物を固体触媒として流動層型カラムをもち
い、基質としてグルコースまたはシユクロースを
使用し、空気または酸素を通気しながら反応させ
ることによりクエン酸が得られることを見出し
た。本発明はかゝる新規な生物工学知見により構
成される。即ち、本発明はゲル状担体に固定した
アスパジラス(Aspergillus)属又はカンジダ
(Candida)属より選ばれたクエン酸生成能を有
する微生物を糖液と接触反応させることを特徴と
する固定化微生物によるクエン酸の製造法であ
る。 The present inventor discovered that Aspergillus niger, which is generally used for citric acid fermentation production,
niger) and Candida lipolyteica (Candida
Cultured microbial cells or spores such as M. lipolytica are entrapping immobilized in various gels of polyacrylamide, Katsupa carrageenan, or calcium alginate, molded into spheres or blocks, and the molded material is used as a solid catalyst to form a fluidized bed column. It was discovered that citric acid can be obtained by using glucose or sucrose as a substrate and performing the reaction while aerating air or oxygen. The present invention is constituted by such novel biotechnological findings. That is, the present invention provides citric acid production using an immobilized microorganism, which is characterized in that a microorganism having the ability to produce citric acid selected from the genus Aspergillus or Candida immobilized on a gel-like carrier is brought into contact with a sugar solution. This is a method for producing acid.
本発明において、クエン酸生成能を有する微生
物としては、クエン酸発酵にて知られるいづれの
属に属する微生物であつても良いが、とりわけク
エン酸生成能が強力であるアスパジラス属、カン
ジダ属微生物、たとえばアスパジラス・ニガーG
−011ATCC1015、カンジダ・リポリテイカ
OUT6340などを好適に用いることができる。さ
らに細菌ではブレビバクテリウム・フラバム
(Brevibacterium flavum)ATCC14067、バチ
ラス・リケニフオルミス(Bacillus
licheniformis)ATCC21667などが適当である。 In the present invention, the microorganism having the ability to produce citric acid may be a microorganism belonging to any genus known for citric acid fermentation, but especially microorganisms of the genus Aspagillus and Candida, which have a strong ability to produce citric acid. For example, Aspadillas niger G.
−011ATCC1015, Candida lipolyteica
OUT6340 or the like can be suitably used. Furthermore, among bacteria, Brevibacterium flavum ATCC14067, Bacillus licheniformis
licheniformis) ATCC21667 etc. are suitable.
これらの培養条件は一般に知られるクエン酸発
酵の場合に、それぞれの菌種に適したものに準ず
れば良い。たとえばアスパジラスの場合は、10%
の甜菜または甘蔗廃糖密液を基本とした培地に、
PH5.8で30℃の通気条件で深部培養する。培地に
は必要に応じ、クエン酸生成に関与する栄養源を
加える。また酵母の場合、10%グルコース、0.2
%塩化アンモニウム、0.05%第1燐酸カリウム、
0.05%硫酸マグネシウム、0.2%酵母エキス、0.01
%チアミンおよび2%炭酸カルシウムを加えた培
地をもちいる方法が代表例として挙げられる。こ
の場合はPH7.0、30℃の通気培養条件がもちいら
れる。これら微生物は集菌、洗滌して次の包括固
定化に供されるが、培養方法は単なる例示であつ
て、何んら本発明を制限するものではない。また
糸状菌(カビ)の場合は固体培養により形成され
る胞子を集め、これを上記深部培養菌体と同様に
本発明に供しうることは勿論である。 These culture conditions may be those suitable for each bacterial species in the case of generally known citric acid fermentation. For example, for aspadillas, 10%
In a medium based on sugar beet or cane sugar concentrate,
Cultivate deep under aeration conditions at 30°C at pH 5.8. A nutrient source involved in citric acid production is added to the medium as necessary. Also for yeast, 10% glucose, 0.2
% ammonium chloride, 0.05% monobasic potassium phosphate,
0.05% Magnesium Sulfate, 0.2% Yeast Extract, 0.01
A typical example is a method using a medium to which % thiamine and 2% calcium carbonate are added. In this case, aerated culture conditions of PH7.0 and 30°C are used. These microorganisms are collected, washed, and then subjected to entrapping immobilization; however, the culture method is merely an example and does not limit the present invention in any way. In the case of filamentous fungi (molds), it is of course possible to collect spores formed by solid-state culture and use them in the present invention in the same manner as the deep-cultured fungi.
上記クエン酸生成能を有する微生物の包括固定
化は通常公知の微生物菌体の固定化法によつて行
なうことができるが、とりわけ、次に示すゲル化
方法を採用すると効果的である。 The entrapping immobilization of the microorganisms capable of producing citric acid can be carried out by a commonly known method for immobilizing microbial cells, but it is particularly effective to employ the gelling method described below.
(1) ポリアクリルアミドを固定化剤とする場合
菌体または胞子を生理食塩水に懸濁したもの
に、アクリルアミドモノマー、N,N′−メチレ
ンビスアクリルアミド、ベーター(β)ジメチル
アミノプロピオニトリルおよび過流酸カリウムを
加え室温に放置してゲル化させる。(1) When polyacrylamide is used as the immobilizing agent A suspension of bacterial cells or spores in physiological saline is added with acrylamide monomer, N,N'-methylenebisacrylamide, beta (β) dimethylaminopropionitrile, and peroxide. Add potassium sulfuric acid and leave at room temperature to gel.
(2) カラギーナンのゲル化方法
上記同様の菌体または胞子を4%カツパ・カラ
ギーナンと共に加温し、スラリーとしたものを注
射器より、2%塩化カリウム液に滴下、球状に成
型ゲル化する。(2) Method for gelling carrageenan The same bacterial cells or spores as above are heated together with 4% Katupa carrageenan, and the slurry is dropped into a 2% potassium chloride solution using a syringe, and formed into a spherical gel.
(3) アルギン酸のゲル化方法
ポリアクリルアミド化方法で記したと同様にし
て得た菌体が、胞子の懸濁液に2%になるようア
ルギン酸ナトリウムを加え、30℃に加温、スラリ
ー化したものを注射器により0.1モル塩化カルシ
ウム溶液中に滴下凝固させ球状ゲル化する。(3) Alginic acid gelation method The bacterial cells obtained in the same manner as described in the polyacrylamidation method were added to a spore suspension with sodium alginate to a concentration of 2%, and heated to 30°C to form a slurry. The material is dropped into a 0.1M calcium chloride solution using a syringe and coagulated to form a spherical gel.
以上に挙げたゲル化法も、単なる例示であり、
ゲル化基剤として、このほかコラーゲン、セルロ
ースサクシネート、カゼインサクシネート、メチ
ルアクリレート、メタアクリル酸共重合体などで
も充分本発明の効果は得られる。 The gelation methods mentioned above are also just examples,
In addition to these gelling bases, collagen, cellulose succinate, casein succinate, methyl acrylate, methacrylic acid copolymers, etc. can also be used to sufficiently obtain the effects of the present invention.
本発明でのクエン酸の製造は、回分式によつて
も、またカラムをもちいる連続接触反応によつて
も実施できる。即ち、固定化菌体または固定化胞
子を、反応に適したPHに調整した緩衝液に懸濁
し、これを円筒型流動層カラムに充填し、これに
例えばグルコース、糖密などの発酵可能な糖を1
%〜20%濃度添加し、カラムの下方からガラスフ
イルター等を通じて通気する。通気は余り強いと
反応効率が悪化する傾向にあるので、固定化微生
物層が余り乱れないように努める。反応温度は、
供試する菌株により多少異なるが30℃附近が良
い。反応液は24時間毎に、新しい溶液と交換し、
反応を継続する。 The production of citric acid in the present invention can be carried out either batchwise or by continuous contact reaction using a column. That is, immobilized bacterial cells or immobilized spores are suspended in a buffer solution adjusted to a pH suitable for the reaction, and this is packed into a cylindrical fluidized bed column, and fermentable sugars such as glucose and molasses are added to the column. 1
% to 20% concentration and ventilate from the bottom of the column through a glass filter, etc. If the aeration is too strong, the reaction efficiency tends to deteriorate, so try not to disturb the immobilized microorganism layer too much. The reaction temperature is
It varies slightly depending on the strain being tested, but a temperature around 30°C is best. Replace the reaction solution with fresh solution every 24 hours.
Continue the reaction.
また連続法による場合、固定化微生物を充填し
たカラムに糖類を含む基質液をペリスタポンプな
どで連続的に送り込み、反応カラムの他方から注
入速度と同じ割合で反応液を流出する。カラムは
必要に応じ温度調節をおこない、反応を至適条件
に保つことにより良い結果を得ることができる。 In the case of a continuous method, a substrate solution containing sugars is continuously fed into a column filled with immobilized microorganisms using a peristaltic pump or the like, and the reaction solution is flowed out from the other side of the reaction column at the same rate as the injection rate. Good results can be obtained by adjusting the temperature of the column as necessary to maintain the reaction at optimal conditions.
以下に実施例をもつて本発明の実態を示すが、
固定化微生物のクエン酸生成能は反応生成したク
エン酸量から求めた。 The actual state of the present invention will be shown below with examples.
The citric acid production ability of the immobilized microorganism was determined from the amount of citric acid produced by the reaction.
実施例 1
麦汁寒天に保存してあつたアスパジラス・ニガ
ーG−011の胞子をPH5.8の10%甜菜廃糖密100ml
を入れた500ml坂口フラスコにて振盪培養し、ク
エン酸生成活性が高い48時間後培養液より菌体を
分離し、水にて洗滌する。該洗滌菌体10gを0.9
%食塩水32mlに懸濁したものにアクリルアミドモ
ノマー6g、N,N′−メチレンビスアクリルア
ミド0.32gを溶解混合し、さらに5%β−ジメチ
ルアミノプロピオニトリル4mlを加え、さらに
2.5%過硫酸カリウム(K2S2O8)4mlをよく混合
し、25℃15分間放置し固定化アスパジラス菌体を
得る。調製されたゲルを4mm3〜5mm3のブロツク
に切断したものを無菌ガーゼの袋につめ円筒型反
応器で通気させながら、シユクロース10%濃度を
含有する100mlの20mM−酒石酸緩衝液(PH3.0)
中で、30℃で、反応せしめ24時間ごとに3回反応
液を交換した。各々24時間反応後で、それぞれ
430mg/dl、435mg/dlおよび428mg/dlのクエン
酸溶液を得た。反応液中には、精製に支障をきた
す他の有機酸の副生はみられなかつた。Example 1 Spores of Aspagillus niger G-011 preserved in wort agar were mixed with 100 ml of 10% sugar beet waste molasses with pH 5.8.
The cells were cultured with shaking in a 500 ml Sakaguchi flask containing 48 hours of high citric acid production activity, and the cells were separated from the culture solution and washed with water. 0.9 g of the washed bacterial cells
Dissolve and mix 6 g of acrylamide monomer and 0.32 g of N,N'-methylenebisacrylamide suspended in 32 ml of % saline solution, add 4 ml of 5% β-dimethylaminopropionitrile, and then
Mix 4 ml of 2.5% potassium persulfate (K 2 S 2 O 8 ) thoroughly and leave to stand at 25° C. for 15 minutes to obtain immobilized Aspagillus cells. The prepared gel was cut into blocks of 4 mm 3 to 5 mm 3 and packed in a sterile gauze bag in a cylindrical reactor with aeration while adding 100 ml of 20 mM tartrate buffer containing 10% sucrose (PH 3.0). )
The reaction solution was exchanged three times every 24 hours at 30°C. After 24 hours of reaction, each
Citric acid solutions of 430 mg/dl, 435 mg/dl and 428 mg/dl were obtained. No other organic acid by-products that would interfere with purification were observed in the reaction solution.
実施例 2
カンジダ・リポリテイカOUT6340菌株を、グ
ルコース10%、NH4Cl0.2%、KH2PO40.05%、
MgSO4・7H2O0.05%、酵母エキス0.2%、0.01%
チアミン及び、2%CaCO3よりなる培養液に接
種し、常法にて30℃、通気条件下で48時間培養す
る。この培養液より菌体を遠心分離にて集め、水
にて洗滌後、固定化工程に供する。Example 2 Candida lipolytica OUT6340 strain was treated with glucose 10%, NH 4 Cl 0.2%, KH 2 PO 4 0.05%,
MgSO4・7H2O0.05 %, yeast extract 0.2%, 0.01%
It is inoculated into a culture solution containing thiamine and 2% CaCO 3 and cultured in a conventional manner at 30°C under aerated conditions for 48 hours. Bacterial cells are collected from this culture solution by centrifugation, washed with water, and then subjected to an immobilization step.
20%菌体濃度になるよう、上記培養洗滌菌体を
2%アルギン酸ナトリウム液に懸濁させ、この溶
液を50ml容注射器につめ、滴下する。この懸濁菌
体液を、あらかじめ撹拌されている0.1M.CaCl2
溶液中に受け固定化する。得られた固定化カンジ
ダ菌体は0.1M−CaCl2溶液中で2時間振盪したの
ち反応に供する。得られた固定化微生物をグルコ
ース10%濃度になるように調製した100mlの
20mMリン酸緩衝液(PH7.0)をもちい実施例1
に準じて反応させた。24時間毎に反応液を交換し
た。それぞれの交換液中の平均クエン酸濃度は
100mg/dlであつた。 Suspend the cultured washed bacterial cells in a 2% sodium alginate solution so that the bacterial cell concentration is 20%, fill this solution into a 50 ml syringe, and drip. This suspended bacterial body fluid was mixed with 0.1M CaCl 2 that had been stirred in advance.
Immobilize in solution. The obtained immobilized Candida cells were shaken for 2 hours in a 0.1M CaCl 2 solution and then subjected to reaction. The obtained immobilized microorganism was added to 100 ml of glucose at a concentration of 10%.
Example 1 using 20mM phosphate buffer (PH7.0)
The reaction was carried out according to the following. The reaction solution was replaced every 24 hours. The average citric acid concentration in each exchange solution is
It was 100mg/dl.
実施例 3
実施例1に準じて得られた固定化アスパジラス
菌体を連続流動層型カラムにつめ、6%シユクロ
ース含有20mM−酒石酸緩衝液(PH3.0)を100ml
通気条件下で4ml/hrの速度で反応操作した。反
応操作開始後4時間目より流出反応生成液を補集
した結果、3mg/mlのクエン酸濃度の溶液が得ら
れた。Example 3 The immobilized Aspagillus cells obtained according to Example 1 were packed into a continuous fluidized bed column, and 100 ml of 20 mM tartrate buffer (PH 3.0) containing 6% sucrose was added.
The reaction was operated at a rate of 4 ml/hr under aerated conditions. As a result of collecting the effluent reaction product liquid from 4 hours after the start of the reaction operation, a solution with a citric acid concentration of 3 mg/ml was obtained.
Claims (1)
(Aspergillus)属又はカンジダ(Candida)属よ
り選ばれたクエン酸生成能を有する微生物を糖液
と接触反応させることを特徴とする固定化微生物
によるクエン酸の製造法。 2 ポリアクリルアミド、カラギーナンおよびア
ルギン酸より選ばれる担体をもちいる特許請求の
範囲第1項記載の固定化微生物によるクエン酸の
製造法。 3 糖液としてグルコース、シユクロース、マル
トースおよびこれらの糖を含有する天然物の抽出
液をもちいる特許請求の範囲第1項記載の固定化
微生物によるクエン酸の製造法。 4 糖液を連続的または間欠的に補給しながら固
定化微生物とを接触反応させる特許請求の範囲第
1項または第3項記載の固定化微生物によるクエ
ン酸の製造法。[Scope of Claims] 1. An immobilized microorganism characterized in that a microorganism having a citric acid-producing ability selected from the genus Aspergillus or Candida immobilized on a gel-like carrier is brought into contact with a sugar solution. Method for producing citric acid by. 2. A method for producing citric acid using an immobilized microorganism according to claim 1, which uses a carrier selected from polyacrylamide, carrageenan, and alginic acid. 3. A method for producing citric acid using an immobilized microorganism according to claim 1, which uses glucose, sucrose, maltose, and extracts of natural products containing these sugars as the sugar solution. 4. A method for producing citric acid using an immobilized microorganism according to claim 1 or 3, in which the immobilized microorganism is subjected to a contact reaction while continuously or intermittently replenishing a sugar solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10134581A JPS585195A (en) | 1981-07-01 | 1981-07-01 | Preparation of citric acid by immobilized microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10134581A JPS585195A (en) | 1981-07-01 | 1981-07-01 | Preparation of citric acid by immobilized microorganism |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS585195A JPS585195A (en) | 1983-01-12 |
JPH038759B2 true JPH038759B2 (en) | 1991-02-06 |
Family
ID=14298242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10134581A Granted JPS585195A (en) | 1981-07-01 | 1981-07-01 | Preparation of citric acid by immobilized microorganism |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS585195A (en) |
-
1981
- 1981-07-01 JP JP10134581A patent/JPS585195A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS585195A (en) | 1983-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0320234B2 (en) | ||
JPS6137919B2 (en) | ||
Chibata et al. | Continuous production of L-aspartic acid: Improvement of productivity by both development of immobilization method and construction of new Escherichia coli strain | |
JPS6156086A (en) | Microbial preparation of alpha-hydroxyacid and its salt | |
CA1215336A (en) | Immobilization of catalytically active microorganisms in agar gel fibers | |
JPS6244914B2 (en) | ||
JPH038759B2 (en) | ||
Murata et al. | Continuous depolymerization of alginates by a non-support bioreactor system containing flocculated bacterial cells | |
JPS6043957B2 (en) | Method for producing gluconic acid using immobilized microorganisms | |
JPS6012037B2 (en) | Production method of itaconic acid using immobilized microorganisms | |
JPH0357757B2 (en) | ||
JPS6258708B2 (en) | ||
JPS60145095A (en) | Preparation of xylitol by immobilized microorganism | |
JP2537355B2 (en) | Method for producing sugar alcohol | |
Chibata | Production of useful chemicals using cells immobilized with polyacrylamide and carrageenan | |
US3783102A (en) | Production of l-asparaginase | |
JPH0634744B2 (en) | Method for producing γ-L-glutamyl-L-α-amino-n-butyrylglycine | |
JP3282271B2 (en) | Method for producing ε-poly-L-lysine | |
JPS5915629B2 (en) | Antibiotic manufacturing method | |
JPH0716379B2 (en) | Soy sauce fermentation equipment | |
RU2420581C1 (en) | Method of producing biocatalyst exhibiting cephalosporin acid synthesis activity | |
RU2093575C1 (en) | Method of hydrolysis of biological substrates | |
JP2830029B2 (en) | Method of removing fumarase activity | |
JPS60120983A (en) | Culture of bacterial cell belonging to brevibacterium genus | |
JPS6324678B2 (en) |